305 related articles for article (PubMed ID: 35179953)
1. Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activity.
Kamerkar S; Leng C; Burenkova O; Jang SC; McCoy C; Zhang K; Dooley K; Kasera S; Zi T; Sisó S; Dahlberg W; Sia CL; Patel S; Schmidt K; Economides K; Soos T; Burzyn D; Sathyanarayanan S
Sci Adv; 2022 Feb; 8(7):eabj7002. PubMed ID: 35179953
[TBL] [Abstract][Full Text] [Related]
2. Reprogramming tumor-associated macrophages by a dually targeted milk exosome system as a potent monotherapy for cancer.
Chen Y; Gong L; Cao Y; Liu Z; Wang Y; Cheng H; Feng Y; Yao S; Yin Y; Wu Z; Huang Z
J Control Release; 2024 Feb; 366():395-409. PubMed ID: 38184235
[TBL] [Abstract][Full Text] [Related]
3. Major vault protein regulates tumor-associated macrophage polarization through interaction with signal transducer and activator of transcription 6.
Yu C; Zhu Q; Ma C; Luo C; Nie L; Cai H; Wang Q; Wang F; Ren H; Yan H; Xu K; Zhou L; Zhang C; Lu G; Lu Z; Zhu Y; Liu S
Front Immunol; 2023; 14():1289795. PubMed ID: 38264642
[TBL] [Abstract][Full Text] [Related]
4. Engineered exoASO-STAT6: a potent monotherapy for oral squamous cell carcinoma.
Jayaseelan VP; Paramasivam A
Future Oncol; 2022 Aug; 18(25):2767-2769. PubMed ID: 35766123
[No Abstract] [Full Text] [Related]
5. Targeting the Stat6 pathway in tumor-associated macrophages reduces tumor growth and metastatic niche formation in breast cancer.
Binnemars-Postma K; Bansal R; Storm G; Prakash J
FASEB J; 2018 Feb; 32(2):969-978. PubMed ID: 29066614
[TBL] [Abstract][Full Text] [Related]
6. A novel targeted iron oxide nanocarrier for inhibiting M2-type macrophages in the tumor microenvironment.
Tian K; Feng R; Wang X; Wu X; Li L; Liu W; Wu R
J Cancer Res Ther; 2022 Sep; 18(5):1409-1416. PubMed ID: 36204890
[TBL] [Abstract][Full Text] [Related]
7. MFHAS1 promotes colorectal cancer progress by regulating polarization of tumor-associated macrophages via STAT6 signaling pathway.
Chen W; Xu Y; Zhong J; Wang H; Weng M; Cheng Q; Wu Q; Sun Z; Jiang H; Zhu M; Ren Y; Xu P; Chen J; Miao C
Oncotarget; 2016 Nov; 7(48):78726-78735. PubMed ID: 27783989
[TBL] [Abstract][Full Text] [Related]
8. YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8
Ma S; Sun B; Duan S; Han J; Barr T; Zhang J; Bissonnette MB; Kortylewski M; He C; Chen J; Caligiuri MA; Yu J
Nat Immunol; 2023 Feb; 24(2):255-266. PubMed ID: 36658237
[TBL] [Abstract][Full Text] [Related]
9. Engineered Bacterial Biomimetic Vesicles Reprogram Tumor-Associated Macrophages and Remodel Tumor Microenvironment to Promote Innate and Adaptive Antitumor Immune Responses.
Zheng P; He J; Fu Y; Yang Y; Li S; Duan B; Yang Y; Hu Y; Yang Z; Wang M; Liu Q; Zheng X; Hua L; Li W; Li D; Ding Y; Yang X; Bai H; Long Q; Huang W; Ma Y
ACS Nano; 2024 Mar; 18(9):6863-6886. PubMed ID: 38386537
[TBL] [Abstract][Full Text] [Related]
10. In Situ Reprogramming of Tumor-Associated Macrophages with Internally and Externally Engineered Exosomes.
Zhang L; Lin Y; Li S; Guan X; Jiang X
Angew Chem Int Ed Engl; 2023 Mar; 62(11):e202217089. PubMed ID: 36658634
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of STAT6 with Antisense Oligonucleotides Enhances the Systemic Antitumor Effects of Radiotherapy and Anti-PD-1 in Metastatic Non-Small Cell Lung Cancer.
He K; Barsoumian HB; Puebla-Osorio N; Hu Y; Sezen D; Wasley MD; Bertolet G; Zhang J; Leuschner C; Yang L; Kettlun Leyton CS; Fowlkes NW; Green MM; Hettrick L; Chen D; Masrorpour F; Gu M; Maazi H; Revenko AS; Cortez MA; Welsh JW
Cancer Immunol Res; 2023 Apr; 11(4):486-500. PubMed ID: 36700864
[TBL] [Abstract][Full Text] [Related]
12. Pulsatilla Saponins Inhibit Experimental Lung Metastasis of Melanoma via Targeting STAT6-Mediated M2 Macrophages Polarization.
Yang X; Wu M; Yan X; Zhang C; Luo Y; Yu J
Molecules; 2023 Apr; 28(9):. PubMed ID: 37175092
[No Abstract] [Full Text] [Related]
13. Targeting MS4A4A on tumour-associated macrophages restores CD8+ T-cell-mediated antitumour immunity.
Li Y; Shen Z; Chai Z; Zhan Y; Zhang Y; Liu Z; Liu Y; Li Z; Lin M; Zhang Z; Liu W; Guan S; Zhang J; Qian J; Ding Y; Li G; Fang Y; Deng H
Gut; 2023 Nov; 72(12):2307-2320. PubMed ID: 37507218
[TBL] [Abstract][Full Text] [Related]
14. Pyropia yezoensis glycoprotein promotes the M1 to M2 macrophage phenotypic switch via the STAT3 and STAT6 transcription factors.
Choi JW; Kwon MJ; Kim IH; Kim YM; Lee MK; Nam TJ
Int J Mol Med; 2016 Aug; 38(2):666-74. PubMed ID: 27353313
[TBL] [Abstract][Full Text] [Related]
15. M1 macrophage exosomes engineered to foster M1 polarization and target the IL-4 receptor inhibit tumor growth by reprogramming tumor-associated macrophages into M1-like macrophages.
Gunassekaran GR; Poongkavithai Vadevoo SM; Baek MC; Lee B
Biomaterials; 2021 Nov; 278():121137. PubMed ID: 34560422
[TBL] [Abstract][Full Text] [Related]
16. Blocking Interleukin (IL)4- and IL13-Mediated Phosphorylation of STAT6 (Tyr641) Decreases M2 Polarization of Macrophages and Protects Against Macrophage-Mediated Radioresistance of Inflammatory Breast Cancer.
Rahal OM; Wolfe AR; Mandal PK; Larson R; Tin S; Jimenez C; Zhang D; Horton J; Reuben JM; McMurray JS; Woodward WA
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):1034-1043. PubMed ID: 29485045
[TBL] [Abstract][Full Text] [Related]
17. Delicaflavone reactivates anti-tumor immune responses by abrogating monocytic myeloid cell-mediated immunosuppression.
Li L; You W; Wang X; Zou Y; Yao H; Lan H; Lin X; Zhang Q; Chen B
Phytomedicine; 2023 Jan; 108():154508. PubMed ID: 36332384
[TBL] [Abstract][Full Text] [Related]
18. Gefitinib inhibits M2-like polarization of tumor-associated macrophages in Lewis lung cancer by targeting the STAT6 signaling pathway.
Tariq M; Zhang JQ; Liang GK; He QJ; Ding L; Yang B
Acta Pharmacol Sin; 2017 Nov; 38(11):1501-1511. PubMed ID: 29022575
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide transcriptome analysis of the STAT6-regulated genes in advanced-stage cutaneous T-cell lymphoma.
Gaydosik AM; Queen DS; Trager MH; Akilov OE; Geskin LJ; Fuschiotti P
Blood; 2020 Oct; 136(15):1748-1759. PubMed ID: 32438399
[TBL] [Abstract][Full Text] [Related]
20. Blocking LTB
Yan J; Zhu J; Li X; Yang R; Xiao W; Huang C; Zheng C
Phytomedicine; 2023 Oct; 119():154968. PubMed ID: 37531900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
